Enhanced iron availability by protein glycation may explain higher infection rates in diabetics

BioMetals

Volumn 25, Issue 1, 2012, Pages 237-245

  Zwang, Theodore J ^a   Gormally, Michael V ^a   Johal, Malkiat S ^a   Sazinsky, Matthew H ^a  

^a POMONA COLLEGE   (United States)

Author keywords

Diabetes; Glycation; Iron homeostasisAlbumin; QCM; Siderophores

Indexed keywords

APOENTEROCHELIN; BOVINE SERUM ALBUMIN; ENTEROCHELIN; HOLOENTEROCHELIN; SIDEROPHORE; UNCLASSIFIED DRUG; ADVANCED GLYCATION END PRODUCT; IRON; PROTEIN;

ARTICLE; BACTERIAL GROWTH; BINDING AFFINITY; CONTROLLED STUDY; DIABETES MELLITUS; ESCHERICHIA COLI; GROWTH RATE; INFECTION RATE; INNATE IMMUNITY; IRON DEPLETION; IRON METABOLISM; NONHUMAN; PROTEIN GLYCOSYLATION; PROTEIN INTERACTION; QUANTITATIVE ANALYSIS; QUARTZ CRYSTAL MICROBALANCE; ANIMAL; CATTLE; CHEMISTRY; GLYCATION; GLYCOSYLATION; GROWTH, DEVELOPMENT AND AGING; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY;

BACTERIA (MICROORGANISMS); BOVINAE;

ANIMALS; CATTLE; DIABETES MELLITUS; ENTEROBACTIN; ESCHERICHIA COLI; GLYCOSYLATION; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; IRON; MAILLARD REACTION; PROTEINS; SERUM ALBUMIN, BOVINE;

EID: 84859484821     PISSN: 09660844     EISSN: 15728773     Source Type: Journal    
DOI: 10.1007/s10534-011-9492-8     Document Type: Article

References (42)

1. Bakala H, Verbeke P, Périchon M, Corman B, Schaeverbeke J (1995) Glycation of albumin with aging and diabetes in rats: changes in its renal handling. Mech Ageing Dev 78:63-71
2. Barnaby OS, Cerny RL, Clarke W, Hage DS (2011) Comparison of modification sites formed on human serum albumin at various stages of glycation. Clin Chim Acta 412:277-285
3. Bierhaus A, Hofmann MA, Ziegler R, Nawroth PP (1998) AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept. Cardiovasc Res 37:586-600
4. Bonay P, Solis J, de la Calle H, Fresno M, Grubb A, Méndez E (1997) Massive glycation of protein HC, a low molecular weight lipocalin, in non-diabetic individuals. FEBS Lett 416:276-280
5. Boyko EJ, Lipsky BA (1995) Infection and diabetes. In: Harris MI, Cowie CC, Stern MP, Boyko EJ, Reiber GE, Bennett PH (eds) Diabetes in America, 2nd edn. U.S. Govt. Printing Office, Washington, DC, pp 485-499 (NIH publ. no. 495-1468)
6. Bullen JJ, Rogers HJ, Spalding PB, Ward CG (2006) Natural resistance, iron and infection: a challenge for clinical medicine. J Med Microbiol 55:251-258
7. Davis TME, Weerarathna T, Foong Y, Mason C, Davis WA (2005) Community acquired infections in type 2 diabetic patients and their non-diabetic partners: the fremantle diabetes study. J Diabetes Complicat 19:259-263
8. Day JF, Thorpe SR, Baynes JW (1979) Nonenzymatically glucosylated albumin. J Biol Chem 254:595-597
9. Dolhofer R, Wieland OH (1980) Increased glycosylation of serum albumin in diabetes mellitus. Diabetes 29:417-422
10. Executive summary: standards of medical care in diabetes- 2009 (2009). Diabetes Care 32:S6-S12
11. Fluckiger R, Winterhalter KH (1976) In vitro synthesis of hemoglobin AIc. FEBS Lett 71:356-360
12. Fujimoto S, Kawakami N, Ohara A (1995) Nonenzymatic glycation of transferrin: decrease of iron-binding capacity and increase of oxygen radical production. Bio Pharm Bull 18:396-400
13. Garlick RL, Mazer JS (1983) The principal site of nonenzymatic glycosylation of human serum albumin in vivo. J Biol Chem 258:6142-6146
14. Harris WR, Carrano CJ, Cooper SR, Sofen SR, Avdeef AE, McArdle JV, Raymond KN (1979) Coordination chemistry of microbial iron transport compounds. 19. Stability constants and electrochemical behavior of ferric enterobactin and model complexes. J Am Chem Soc 101:6097-6104
15. Hinton DJS, Ames JM (2006) Site specificity of glycation and carboxymethylation of bovine serum albumin by fructose. Amino Acids 30:425-433
16. Huebschmann AG, Regensteiner JG, Vlassara H, Reusch JEB (2006) Diabetes and advanced glycoxidation end products. Diabetes Care 29:1420-1432
17. Kawakami K, Yasuda M, Ishii K, Kokusenya Y, Sato T (1999) A kinetic study of protein binding to ecabet sodium using quartz-crystal microbalance. Chem Pharm Bull 47: 919-922
18. Kisugi R, Kouzuma T, Yamamoto T, Akizuki S, Miyamoto H, Someya Y, Yokoyama J, Abe I, Hirai N, Ohnishi A (2007) Structural and glycation site changes of albumin in diabetic patient with very high glycated albumin. Clin Chim Acta 382:59-64
19. Konopka K, Neilands JB (1984) Effect of serum albumin on siderophore-mediated utilization of transferrin iron. Biochemistry 23:2122-2127
20. Kublashvili RI, Ugrekhelidze DS (2005) Glycosylation of bovine serum albumin with D-[14C]-glucose. Chem Nat Comp 41:340-343
21. Li YM, Mitsuhashi T, Wojciechowicz D, Shimizu N, Li J, Stitt A, He C, Banerjee D, Vlassara H (1996) Molecular identity and cellular distribution of advanced glycation endproduct receptors: relationship of p60 to OST-48 and p90 to 80 K-H membrane proteins. Proc Nat Acad Sci USA 93:11047-11052
22. Mereish KA, Rosenberg H, Cobby J (1982) Glucosylated albumin and its influence on salicylate binding. J Pharm Sci 71:235-238
23. Miethke M, Marahiel MA (2007) Siderophore-based iron acquisition and pathogen control. Microbiol Mol Biol Rev 71:413-451
24. Mohamadi-Nejad A, Moosavi-Movahedi AA, Hakimelahi GH, Sheibani N (2002) Thermodynamic analysis of human serum albumin interactions with glucose: insights into diabetic range of glucose concentration. Int J Biochem Cell Biol 34:1115-1124
25. Neilands JB (1981) Development of iron chelators for clinical use. In: Martell AE, Anderson WF, Badman DG (eds). Elsevier North-Holland, New York, pp 13-31
26. Nguyen A, Reyes AE, Zhang M, McDonald P, Wong WLT, Damico LA, Dennis MS (2006) The pharmacokinetics of an albumin-binding Fab (AB.Fab) can be modulated as a function of affinity for albumin. Protein Eng Des Sel 19:291-297
27. Payne SM (1994) Detection, isolation, and characterization of siderophores. In: Clark VL, Bavoil PM (eds) Methods in enzymology, bacterial pathogenesis, Part A: identification and regulation of virulence factors, vol 235. Academic Press, Oxford, pp 329-344
28. Peleg AY, Weerarathna T, McCarthy JS, Davis TME (2007) Common infections in diabetes: pathogenesis, management and relationship to glycemic control. Diabetes Metab Res Rev 23:3-13
29. Prevention CfDCa (2008) National diabetes fact sheet: general information and national estimates on diatebetes in the United States, 2007
30. Rayfield EJ, Ault MJ, Keusch GT, Brothers MJ, Nechemias C, Smith H (1982) Infection and diabetes: the case for glucose control. Am J Med 72:439-450
31. Raymond KN, Dertz EA, Kim SS (2003) Enterobactin: an archetype for microbial iron transport. Proc Nat Acad Sci USA 100:3584-3588
32. Rich J, Lee JC (2005) The pathogenesis of Staphylococcus aureus infection in the diabetic NOD mouse. Diabetes 54:2904-2910
33. Rodahl M, Höök F, Krozer A, Brzezinski P, Kasemo B (1995) Quartz-crystal microbalance setup for frequency and Q-factor measurements in gaseous and liquid environments. Rev Sci Instrum 66:3924-3930
34. Roohk HV, Zaidi AR (2008) A review of glycated albumin as an intermediate glycation index for controlling diabetes. J Diabetes Sci Technol 2:1114-1121
35. Roy A, Sen S, Chakraborti AS (2004) In vitro nonenzymatic glycation enhances the role of myoglobin as a source of oxidative stress. Free Radic Res 38:139-146
36. Sauerbrey G (1959) Verwendung von schwingquarzen zur wägung dünner schichten und zur mikrowägung. Zeitschrift fü r Physik 155:206-222
37. Sen S, Kar M, Roy A, Chakraborti AS (2005) Effect of nonenzymatic glycation on functional and structural properties of hemoglobin. Biophys Chem 113:289-298
38. Shaklai N, Garlick RL, Bunn HF (1984) Nonenzymatic glycosylation of human serum albumin alters its conformation and function. J Biol Chem 259:3812-3817
39. Shetty JK, Prakash M, Ibrahim MS (2008) Relationship between free iron and glycated hemoglobin in uncontrolled type 2 diabetes patients associated with complications. Ind J Clin Biochem 23:67-70
40. Suárez G, Rajaram R, Oronsky AL, Gawinowicz MA (1989) Nonenzymatic glycation of bovine serum albumin by fructose (fructation). Comparison with the Maillard reaction initiated by glucose. J Biol Chem 264:3674-3679
41. Tessier FJ (2010) The Maillard reaction in the human body. The main discoveries and factors that affect glycation. Pathol Biol 58:214-219
42. Wilhelm SW, MacAuley K, Trick CG (1998) Evidence for the importance of catechol-type siderophores in the ironlimited growth of a cyanobacterium. Limnol Oceanogr 43:992-997